Table 3.
Study | No. patients | Focal, no. (%) | Diffuse | Further examination | FNAC/operation | Cancer, no. (%) | Pathology (micro) | SUV |
---|---|---|---|---|---|---|---|---|
Cohen et al.6 | 4 525 | 71 (1.6) | 31 | NA | 15/NA | 7 (47.0) | 3 PTC 2 poorly differentiated PTC |
Useful |
Kim et al.9 | 4 136 | 45 (1.1) | 45 | NA | 32/7 | 18 (56.0) | 14 PTC 2 metastatic 2 follicular thyroid cancer |
NS |
Chen et al.7 | 4 803 | 60 (1.2) | — | 50 | — | 7 (14.0) | 7 PTC | Useful |
Choi et al.8 | 1 763 | 70 (4.0) | — | 44 | 29/NA | 17 (38.6) | 16 PTC | Useful |
Are et al.5 | 8 800 | 101 (1.1) | 162 | 57 | 57/27 | 24 (42.0) | 19 PTC | NS |
Chu et al.11 | 6 241 | 76 (1.2) | — | — | 14/1 | 4 (28.6) | 4 PTC | NA |
Bogsrud et al.10 | 7 347 | 79 (1.1) | — | 48 | NA/11 | 15 (31.3) | 12 PTC 2 metastatic |
NS |
King et al.16 | 15 711 | 22 (0.1) | — | 21 | 21/14 | 7 (32.0) | 6 PTC (4) 1 MTC |
NA |
Nishimori et al.* | 4 726 | 103 (2.2) | 57 | 50 | 30/10 | 9 (30.0) | 8 PTC (2) 1 poorly differentiated PTC |
NS |
FNAC = fine-needle aspiration cytology; MCT = medullary thyroid cancer; NA = not available; NS = not significant; PTC = papillary thyroid cancer; SUV = standardized uptake value.
Unpublished data, 2008.